David Baltimore

11PUBLICATIONS
50CO-AUTHORS
Molecular targetsHaematological tumoursMedical devicesTumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 15, 2026
Sequential transcriptional waves and NF-κB-driven chromatin remodeling direct drug-induced dedifferentiation in cancer.

|Jul 02, 2025
Human cancer-targeted immunity via transgenic hematopoietic stem cell progeny.

Theodore S Nowicki, Nataly Naser Al Deen, Cole W Peters

|Nov 10, 2022
Non-viral precision T cell receptor replacement for personalized cell therapy.

Susan P Foy, Kyle Jacoby, Daniela A Bota

|Apr 12, 2022
Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial.

Joseph P Casazza, Evan M Cale, Sandeep Narpala

|May 13, 2020
Multi-omic single-cell snapshots reveal multiple independent trajectories to drug tolerance in a melanoma cell line.

Yapeng Su, Melissa E Ko, Hanjun Cheng

|Aug 01, 2019
Alternative mRNA splicing in cancer immunotherapy.

Luke Frankiw, David Baltimore, Guideng Li

Pageof 2

Frequent Collaborators

5 joint publications

Guideng Li

4 joint publications

Antoni Ribas

3 joint publications

James R Heath

2 joint publications

Jocelyn T Kim